[Body mass index in asthmatic children before and after one year inhaled glucocorticosteroids therapy BMI]

Related Experiment Video

Updated: Jun 5, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Gordana Kostić1, Nevenka Ilić, Marina Petrović

  • 1Klinicki centar Kragujevac, Klinika za pedijatriju. koleg@sbb.co.rs

Medicinski Pregled
|December 29, 2010
PubMed

Insights

This study found that most children with asthma have a normal body mass index (BMI). Continuous use of inhaled corticosteroids (ICS) for asthma treatment did not negatively impact children's growth over one year.

Area of Science:

  • Pediatric Allergy and Pulmonology
  • Pediatric Endocrinology
  • Childhood Asthma Research

Context:

  • Asthma is a prevalent childhood condition with increasing incidence.
  • Controversy exists regarding obesity prevalence in asthmatic children.
  • Potential impact of inhaled corticosteroids (ICS) on pediatric growth requires investigation.

Purpose:

  • To assess body mass index (BMI) in children with asthma before and after one year of ICS therapy.
  • To evaluate the effect of continuous ICS treatment on the growth and BMI of asthmatic children.

Summary:

  • The study included 100 children (7-18 years) with partly controlled/uncontrolled allergic asthma receiving continuous ICS.
  • Initial assessment revealed 70% of children had normal BMI, 10% were underweight, and 18% were overweight/obese.
  • After one year, ICS therapy showed a statistically significant positive effect on height across most age groups, with no adverse impact on BMI.

Impact:

  • Provides evidence that inhaled corticosteroids (ICS) are safe for pediatric asthma management regarding growth.
  • Suggests that asthmatic children, even with uncontrolled disease, generally maintain normal BMI.
  • Informs clinical practice on the long-term effects of ICS on growth in pediatric asthma patients.
Abstract

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...